Last reviewed: April 21, 2026 Updated with Phase 3 TRIUMPH-4 data Primary sources: NEJM, Eli Lilly, ClinicalTrials.gov Retatrutide is a triple agonist (GLP-1 + GIP + glucagon) currently in Phase 3 trials, showing stronger early weight loss data
If you are also taking other medications for blood sugar management, doubling up on your GLP-1 dose could cause your blood sugar to drop to dangerous levels, leading to dizziness, confusion, or fainting
DOI First-in-human safety study of LY3437943, including how the body absorbs and clears it
Our team of experts will be glad to explain the details of the various skincare treatments that are available and assist you in choosing the best one for you
But do they really comply
All three approved injection sitesabdomen, thigh, and upper armprovide similar medication absorption rates when proper subcutaneous technique is used